Clinical trial
A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck…
NCT00038584 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00038584 |
|---|---|
| Title | A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer |
| Official title | A Phase IB Study of Oral Administration of SCH 66336 Preoperatively in Patients With Head and Neck Squamous Cell Cancer Scheduled for Definitive Therapy |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma, Squamous Cell, Cancer of Head and Neck |
| Intervention type | Drug |
| Interventions | SCH66336 |
| Enrollment | 37 |
| Start date | Jun 1, 1999 |
| Primary completion | Nov 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Jun 3, 2002 |
| Last update posted | Oct 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: